tiprankstipranks
Trevi Therapeutics Inc (TRVI)
NASDAQ:TRVI
US Market
TRVI
Trevi Therapeutics
RESEARCH TOOLSreports
Want to see TRVI full AI Analyst Report?

Trevi Therapeutics (TRVI) Stock News & Sentiment

589 Followers
Trevi Therapeutics Prices Public Offering to Fund Haduvio
Premium
Company Announcements
Trevi Therapeutics Prices Public Offering to Fund Haduvio
17d ago
8K
TRVI
Trevi Therapeutics: Positive Needham Conference Takeaways Reinforce Buy Rating and Favorable Risk‑Reward Profile
Premium
Ratings
Trevi Therapeutics: Positive Needham Conference Takeaways Reinforce Buy Rating and Favorable Risk‑Reward Profile
20d ago
TRVI
Trevi Therapeutics Maps Phase III Path and Runway
Premium
Company Announcements
Trevi Therapeutics Maps Phase III Path and Runway
2M ago
TRVI
TRVI Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
TRVI Earnings this Week: How Will it Perform?
2M ago
TRVI
Trevi Therapeutics Aligns With FDA on Phase 3 Cough Trials
Premium
Company Announcements
Trevi Therapeutics Aligns With FDA on Phase 3 Cough Trials
2M ago
8K
TRVI
De-Risked Phase 3 Strategy and FDA Alignment Underpin Buy Rating on Trevi for Haduvio in IPF Cough
Premium
Ratings
De-Risked Phase 3 Strategy and FDA Alignment Underpin Buy Rating on Trevi for Haduvio in IPF Cough
2M ago
TRVI
Advancing Haduvio in IPF-Related Chronic Cough: FDA-Endorsed Phase 3 Path and Strong Cash Position Underscore Undervalued Multibillion-Dollar Opportunity for Trevi
Premium
Ratings
Advancing Haduvio in IPF-Related Chronic Cough: FDA-Endorsed Phase 3 Path and Strong Cash Position Underscore Undervalued Multibillion-Dollar Opportunity for Trevi
2M ago
TRVI
More TRVI News >

TRVI News on the Web

Unusually active option classes on open April 17th
TipRanks News
Neutral
Trevi Therapeutics Prices Public Offering to Fund Haduvio
TipRanks News
Neutral
Trevi Therapeutics Prices $150 Million Offering, Bolstering Funding for Chronic Cough Research
Market Chameleon
Neutral
Trevi Therapeutics 11.6M share Spot Secondary priced at $13.00
TipRanks News
Neutral
Trevi Hits 52-Week High After Public Offering Pricing
rttnews
Bullish
Trevi Therapeutics Raises $150 Million in Public Offering to Advance Chronic Cough Therapy Development
Market Chameleon
Bullish
Closing Bell Movers: Netflix down 9% as Q2 outlook misses, Hastings leaves board
TipRanks News
Bearish
Trevi Therapeutics announces $150M common stock offering
TipRanks News
Neutral

News Score - Last 7 Days

Positive
TRVI
Sector Average
Media Buzz
This Week9 articles
Weekly Average3.75 articles
News Sentiment
This Week75%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is TRVI’s Media Buzz Sentiment?
9 articles about TRVI were published this week. In an average week, 3.75 articles are published.
    What is TRVI’s weekly average amount of articles?
    In an average week, 3.75 articles about TRVI are published.
      What is TRVI’s News Sentiment?
      75% of articles about TRVI were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week